An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes

Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression

(2013) M. Ruscica et al.   CURRENT MOLECULAR MEDICINE

Histopathology of gastrointestinal neuroendocrine neoplasms

(2013) Kenichi Hirabayashi et al.   Frontiers in Oncology

Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations

(2012) D J Pinato et al.   BRITISH JOURNAL OF CANCER

Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma

(2012) David James Pinato et al.   Journal of Thoracic Oncology

Angiogenesis in Neuroendocrine Tumors: Therapeutic Applications

(2012) Jean-Yves Scoazec   NEUROENDOCRINOLOGY

Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms

(2011) Günter Klöppel   ENDOCRINE-RELATED CANCER

Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors

(2011) Francesco Panzuto et al.   NEUROENDOCRINOLOGY

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

(2011) Eric Raymond et al.   NEW ENGLAND JOURNAL OF MEDICINE

Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors

(2011) Patricia Kuiper   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical Significance of Protein Expression of Cyclooxygenase-2 and Somatostatin Receptors in Gastroenteropancreatic Neuroendocrine Tumors

(2011) Hee Sung Kim et al.   Cancer Research and Treatment

Hypoxia stimulates CXCR4 signalling in ileal carcinoids

(2010) Yvonne Arvidsson et al.   ENDOCRINE-RELATED CANCER

Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors

(2010) Dermot O'Toole et al.   ENDOCRINE-RELATED CANCER

VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway

(2010) Karine Villaume et al.   NEUROENDOCRINOLOGY

Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis

(2010) Imke Albrecht et al.   PLoS One

Pancreatic Endocrine Microadenomatosis in Patients With von Hippel-Lindau Disease

(2009) Martine Pé rigny et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

(2009) Anja Rinke et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival and Prognostic Factor Analysis of 146 Metastatic Neuroendocrine Tumors of the Mid-Gut

(2009) Jonathan Strosberg et al.   NEUROENDOCRINOLOGY

Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors

(2008) David C. Metz et al.   GASTROENTEROLOGY

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Gastroenteropancreatic neuroendocrine tumours

(2008) Irvin M Modlin et al.   LANCET ONCOLOGY

Somatostatin Receptor Subtypes 2 and 5 Are Associated with Better Survival in Well-Differentiated Endocrine Carcinomas

(2008) Vito D. Corleto et al.   NEUROENDOCRINOLOGY